Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:616-622
Published online before print February 13, 2003, doi: 10.1161/01.STR.0000058157.69113.F6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v34,p1338)
Right arrow All Versions of this Article:
34/3/616    most recent
01.STR.0000058157.69113.F6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonçalves, I.
Right arrow Articles by Ares, M. P.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonçalves, I.
Right arrow Articles by Ares, M. P.S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*HYDROXYAPATITE
Medline Plus Health Information
*Carotid Artery Disease
*Seniors' Health
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Pathophysiology
Right arrow Carotid Stenosis
Right arrow Pathology of Stroke

(Stroke. 2003;34:616.)
© 2003 American Heart Association, Inc.


Original Contributions

Changes Related to Age and Cerebrovascular Symptoms in the Extracellular Matrix of Human Carotid Plaques

Isabel Gonçalves, MD; Jonatan Moses, PhD; Nuno Dias, MD; Luís M. Pedro, MD; José Fernandes e Fernandes, MD, PhD; Jan Nilsson, MD, PhD Mikko P.S. Ares, PhD

From the Department of Medicine, Lund University, Wallenberg Laboratory, University Hospital MAS, Malmö, Sweden (I.G., J.N., M.P.S.A.); Wallenberg Laboratory for Cardiovascular Research, Matrix and Proteoglycan Group, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (J.M.); and Instituto Cardiovascular de Lisboa, Lisbon, Portugal (N.D., L.M.P., J.F.F.).

Correspondence to Isabel Gonçalves, MD, Lund University, Wallenberg Laboratory, University Hospital MAS, S-20502 Malmö, Sweden. E-mail isabel.goncalves{at}medforsk.mas.lu.se

Background and Purpose— Many processes involved in the pathogenesis of atherosclerosis result in modifications of the extracellular matrix. These changes not only determine the mechanical stability of atherosclerotic lesions but can directly or indirectly influence further development of the lesions. The purpose of the present study was to compare the matrix composition of human carotid plaques from symptomatic patients with those obtained from patients without symptoms. Furthermore, matrix changes related to age were studied.

Methods— Thirty atherosclerotic carotid plaques were removed by endarterectomy from 27 patients and divided into 2 groups on the basis of the presence of ipsilateral symptoms. The plaques were homogenized, and the total levels of the major components of the extracellular matrix were determined.

Results— Plaques associated with symptoms were characterized by increased levels of elastin (1.58±0.46 versus 1.24±0.40 mg/g wet wt; P=0.03) and decreased levels of hydroxyapatite (45.1±46.3 versus 131.4±111.7 mg/g wet wt; P=0.02) compared with asymptomatic plaques. The increase in elastin in plaques from symptomatic patients was due to elevated levels of an intermediate-size fraction, as determined by liquid chromatography. Collagen and sulfated glycosaminoglycans were present in equal amounts in both groups. Elastin content in carotid plaques decreased with age.

Conclusions— Carotid plaques from symptomatic patients have lower levels of hydroxyapatite than those from asymptomatic patients. The present study also raises the possibility that non–cross-linked forms of elastin, increased in plaques associated with symptoms, could be a marker of plaque vulnerability and/or directly induce harmful cellular activities or increase lipoprotein retention in the vascular wall.


Key Words: aging • atherosclerosis • carotid stenosis • elastin




This article has been cited by other articles:


Home page
StrokeHome page
I. Goncalves, M. W. Lindholm, L. M. Pedro, N. Dias, J. Fernandes e Fernandes, G. N. Fredrikson, J. Nilsson, J. Moses, and M. P.S. Ares
Elastin and Calcium Rather Than Collagen or Lipid Content Are Associated With Echogenicity of Human Carotid Plaques
Stroke, December 1, 2004; 35(12): 2795 - 2800.
[Abstract] [Full Text] [PDF]